Focal muscle vibration to limit leg muscle weakness during reduced use
Official title: Effects of Focal Muscle Vibration as a Countermeasure Against Hypoactivity-induced Neuromuscular Deconditioning
Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07021079 · Data updated 2026-11-12
This trial will see if a 10-day program of focal muscle vibration can limit strength loss in healthy adults whose one leg is temporarily unloaded.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 45 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 1 site (Saint-Etienne) |
| Status | Recruiting |
| Started | June 16, 2025 |
| Main results expected | June 1, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT07021079 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy men and women aged 18–45 with BMI 20–25 kg/m² who do at least 1.5 hours of physical activity per week and have no major medical or neuroactive medication contraindications.
✕Probably not a fit
People with chronic cardiovascular, neuromuscular, bone, metabolic or inflammatory disorders, recent trauma, thrombosis risk, or who take neuroactive drugs are unlikely to be eligible or to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will use a unilateral lower limb suspension model to mimic hypoactivity and compare a 10-day focal muscle vibration (FMV) protocol versus no vibration. FMV targets muscle spindle afferents and can produce cortical and spinal adaptations that influence neural drive to muscle. The study will measure changes in muscle strength and neuromuscular excitability to determine whether FMV reduces deconditioning. If effective, FMV could be a simple, non-invasive countermeasure during periods of immobilization.
Why it matters
Potential benefit: If successful, this approach could reduce strength loss during short-term leg unloading and improve recovery after immobilization.
How similar studies have gone: Previous experimental and rehabilitation studies of focal muscle vibration have reported neural adaptations and strength gains, but large clinical trials in immobilization models remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women. * Aged 18 to 45 years. * Body Mass Index (BMI) between 18,5 and 24,9 kg/m². * Engaging in at least 1.5 hours per week of physical activity (e.g., brisk walking, running, swimming, cycling). * Provided informed consent after receiving detailed information about the study. * Affiliated with or beneficiaries of a social security system Exclusion Criteria: * Chronic cardiovascular, neuromuscular, bone, metabolic, and/or inflammatory disorders. * Personal history and/or risk factors for thrombosis. * Use of antidepressant medications. * Use of neuroactive substances likely to alter corticospinal excitability (e.g., hypnotics, antiepileptics, psychotropics, muscle relaxants) during the study. * Recent bone or ligament trauma within the past 12 months. * Inability to perform the physical efforts required for the study. * Recent participation in a sporting competition or intense, unusual physical activity within the past month. * Corticosteroid treatment within the past 3 months. * Any skin lesions at the planned vibrator application site. * Simultaneous participation in another interventional medical study. * Pregnant or breastfeeding women. * Individuals unable to understand the purpose and conditions of the study or unable to provide informed consent. * Individuals deprived of liberty or under guardianship
Where it's running
-
Centre Hospitalier Universitaire
Saint-Etienne, France Recruiting
Study contacts
- Principal investigator: Leonard Feasson, Phd — Centre Hospitalier Universitaire Saint-Etienne
- Study coordinator: Leonard Feasson, Phd
- Email: leonard.feasson@chu-st-etienne.fr
- Phone: (0)477120383
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Morning-strength boost with caffeine or whole-body vibration
This study tests whether taking 300 mg caffeine or using whole-body vibration helps healthy, regularly trained adults see improvements in morning strength and thinking skills.
-
Pfizer medicine PF-08103402: how different doses are tolerated in healthy adults and adults with mild-to-moderate asthma
This study tests how different amounts of PF-08103402 behave in the body and how well it is tolerated by healthy adults and adults with mild-to-moderate asthma.
-
Robotic walking with added targeted vibration to improve post-stroke gait
This trial tests whether adding Vibramoov® vibration therapy to Lokomat® robotic gait training helps people after stroke walk better.
-
Trying ViBandz for children with neurologic movement problems
We will try the ViBandz vibration device with children aged 6 months to 17 years who have neurologic movement problems during their regular PT/OT clinic visit.
-
Comparing how three adhesive dressings stay on the skin
We will test how well three different self-adhesive dressings stick to and stay on the back of healthy adults.
-
Kidney responses to exercise in heat and whether vitamin B3 changes them.
This project will test whether taking vitamin B3 changes how the kidneys respond when healthy, physically fit adults exercise in hot, humid conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.